Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tejaswini BN"'
Publikováno v:
2022 6th International Conference on Intelligent Computing and Control Systems (ICICCS).
Autor:
Amritanshu Ram, Ashwini R, Mithua Ghosh, Nimmy Ramdas, Satheesh C.T, Sateesh S. Kunigal, K. Murugan, Urvashi Bahadur, Raghavendra M Rao, B. Mahesh, Ajai Kumar, Sheela Ml, Pooja Agrawal, Radheshyam Naik, K. C. Ramya, Tejaswini Bn, Sunitha N, Pooja Sridhar, Nalini Rao, R. Veena, Shekar Patil, Srinivas B.J, Shanmukh Katragadda, Krishna Cr, Shashidhara H P, Yogesh S, Ashwini Manjunath
Publikováno v:
International e-Conference on Cancer Research 2019.
Autor:
Shalaka Somayaji, Beulah Elsa Thomas, Vinayak Munirathnam, Lalram Sangi, Samuel Luke Koramati, Basavalinga S. Ajaikumar, Satheesh Chiradoni Thungappa, Radheshyam Naik, Lalnun Puii, Tejaswini Bn, Smruthy Ann Mathew, Hrishi Varayathu, Shivakumar Swamy, Suhail Sayeed Mufti, Sriniivas Bj
Publikováno v:
Journal of Clinical Oncology. 39:e12570-e12570
e12570 Background: Gene expression profiling for breast cancer has classified ER positive subtype into luminal A and luminal B. Luminal B breast cancer (LBBC) have a higher proliferation and poorer prognosis than luminal A tumors. Ki-67 index is the
Autor:
Diganta Hazarika, Radheshyam Naik, Tejaswini Bn, Lalram Sangi, Vinu Sarathy, Suhail Sayeed Mufti, Satheesh Chiradoni Thungappa, Beulah Elsa Thomas, Basavalinga S. Ajaikumar, Sriniivas Bj, Hrishi Varayathu, Shekar Patil, Lalnun Puii, Bhanu Prakash Lalkota
Publikováno v:
Journal of Clinical Oncology. 38:1078-1078
1078 Background: Androgen receptor (AR) expressing triple negative breast cancer (TNBC) is a sub-set of TNBC with an evolving prognostic and predictive behaviour. AR immunohistochemical threshold for positivity has not been standardized and a wide ra
Publikováno v:
IOSR Journal of Computer Engineering. 16:72-82
In this paper we propose an energy efficient multicasting congestion control protocol for mobile ad hoc networks (MANETs) over fading channels. Our proposed scheme overcomes the disadvantages of existing multicast congestion control protocols which d
Autor:
BS Kumar, H P Shashidhara, Rao, A Gangoli, Shivanand Patil, Ravi B Diwakar, Shilpa Prabhudesai, C T Satheesh, J Dixit, Diganta Hazarika, R Tejaswi, S Kakara, Vidya H Veldore, N Krishnamoorthy, KS Gopinath, Shamir Rahman, Radheshyam Naik, Subhrendu K. Pattanayak, Tejaswini Bn
Publikováno v:
Indian journal of cancer. 51(4)
Background: One of the genetic alterations implicated in tumor progression in colorectal cancers (CRCs) are abnormalities in Kristen Rat Sarcoma (KRAS) gene. Evaluation of KRAS mutation status is an important prognostic factor and has predictive valu
Autor:
S A Gangoli, R Tejaswi, Shamir Rahman, Shilpa Prabhudesai, C T Satheesh, S Patil, Raghavendra M Rao, Diganta Hazarika, Radheshyam Naik, Tejaswini Bn, Ravi B Diwakar, S Kakara, Rashmita Sahoo, Vidya H Veldore, Subhrendu K. Pattanayak, S P Shashidhar, E Venkataswamy, N Krishnamoorthy, B S Ajai Kumar
Publikováno v:
Indian journal of cancer. 50(2)
Background: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the prognosis of patients with lung cancer. However, there is a dearth of studies on EGFR mutation in Indian population. In this retrospective study conducted at a net
Autor:
S. Patil, Diganta Hazarika, Radheshyam Naik, Syed m Rahaman, Basavalinga S. Ajaikumar, Tejaswini Bn, Tejaswi Routhu, Satheesh Chiradoni Thungappa, Shashidhara Sp, N Krishnamoorthy, Shilpa Prabhudesai, Veldore H. Vidya, Rao M. Raghavendra, Payal Shrivastava
Publikováno v:
Journal of Clinical Oncology. 32:e22158-e22158
e22158 Background: NSCLC is a broad category of lung cancer with multiple subsets of molecular abnormalities. EGFR mutation positive patients constitute 30-50% of NSCLC, and hence they derive the b...
Autor:
Ramaswamy V; Department of Histopathology, Strand Life Sciences - Health Care Global Cancer Hospital, Bengaluru, Karnataka, India., Tejaswini BN; Department of Histopathology, Strand Life Sciences - Health Care Global Cancer Hospital, Bengaluru, Karnataka, India., Uthaiah SB; Department of Histopathology, Strand Life Sciences - Health Care Global Cancer Hospital, Bengaluru, Karnataka, India.
Publikováno v:
Journal of pathology informatics [J Pathol Inform] 2021 Apr 08; Vol. 12, pp. 20. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021).
Autor:
Veldore VH; Department of Molecular Pathology, Triesta Reference Laboratory, Triesta Sciences, A unit of Healthcare Global Enterprises Ltd., Bengaluru, Karnataka, India., Rao MR, Prabhudesai SA, Tejaswi R, Kakara S, Pattanayak S, Krishnamoorthy N, Tejaswini BN, Hazarika D, Gangoli A, Rahman SM, Dixit J, Naik R, Diwakar RB, Satheesh CT, Shashidhara HP, Patil S, Gopinath KS, Kumar BS
Publikováno v:
Indian journal of cancer [Indian J Cancer] 2014 Oct-Dec; Vol. 51 (4), pp. 531-7.